Anadys Pharmaceuticals, Inc.

Apollon Inc. , for example, was a naked DNA vaccines company spun off by Centocor in 1992 (well before Centocor itself was acquired by Johnson & Johnson ). A $100 million deal in 1995 for vaccine

San Diego-based eFFECTOR Therapeutics has raised $45 million in Series A venture capital to develop small molecules that selectively regulate protein synthesis – otherwise known as translation – and a

Since when did biotech’s epicenter move to Pamplona? The bull run has lasted quite a while now, after having gotten an extra goose, if you don’t mind mixing barnyard metaphors, around the time hepatit

Two years after selling Anadys Pharmaceuticals Inc. to Roche , Steve Worland has started a new entrepreneurial project by linking novel science with enthusiastic early-stage investors. Newly la